Aligos therapeutics announces proposed public offering of common stock

South san francisco, calif., june 28, 2021 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs) today announced that it has commenced an underwritten public offering of 4,000,000 shares of common stock. in addition, aligos intends to grant the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock. all of the shares of common stock are being offered by aligos. the offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
ALGS Ratings Summary
ALGS Quant Ranking